534 related articles for article (PubMed ID: 26984727)
1. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
2. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
Julik E; Reyes-Del Valle J
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
[TBL] [Abstract][Full Text] [Related]
3. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
4. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
[TBL] [Abstract][Full Text] [Related]
6. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
7. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
8. The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles.
Lobanova LM; Eng NF; Satkunarajah M; Mutwiri GK; Rini JM; Zakhartchouk AN
Vaccine; 2012 Apr; 30(20):3061-7. PubMed ID: 22406109
[TBL] [Abstract][Full Text] [Related]
9. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.
Pan CH; Valsamakis A; Colella T; Nair N; Adams RJ; Polack FP; Greer CE; Perri S; Polo JM; Griffin DE
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11581-8. PubMed ID: 16037211
[TBL] [Abstract][Full Text] [Related]
10. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
12. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
[TBL] [Abstract][Full Text] [Related]
13. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.
Durbin AP; Skiadopoulos MH; McAuliffe JM; Riggs JM; Surman SR; Collins PL; Murphy BR
J Virol; 2000 Aug; 74(15):6821-31. PubMed ID: 10888621
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.
Qi Y; Xing K; Zhang L; Zhao F; Yao M; Hu A; Wu X
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1945-1957. PubMed ID: 30090962
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.
Iankov ID; Haralambieva IH; Galanis E
Vaccine; 2011 Feb; 29(8):1710-20. PubMed ID: 21182995
[TBL] [Abstract][Full Text] [Related]
16. Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice.
Huang Z; Dry I; Webster D; Strugnell R; Wesselingh S
Vaccine; 2001 Feb; 19(15-16):2163-71. PubMed ID: 11228389
[TBL] [Abstract][Full Text] [Related]
17. C3d enhancement of neutralizing antibodies to measles hemagglutinin.
Green TD; Newton BR; Rota PA; Xu Y; Robinson HL; Ross TM
Vaccine; 2001 Oct; 20(1-2):242-8. PubMed ID: 11567770
[TBL] [Abstract][Full Text] [Related]
18. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
Rennick LJ; de Vries RD; Carsillo TJ; Lemon K; van Amerongen G; Ludlow M; Nguyen DT; Yüksel S; Verburgh RJ; Haddock P; McQuaid S; Duprex WP; de Swart RL
J Virol; 2015 Feb; 89(4):2192-200. PubMed ID: 25473055
[TBL] [Abstract][Full Text] [Related]
19. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
Pan CH; Jimenez GS; Nair N; Wei Q; Adams RJ; Polack FP; Rolland A; Vilalta A; Griffin DE
Clin Vaccine Immunol; 2008 Aug; 15(8):1214-21. PubMed ID: 18524884
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
